267 related articles for article (PubMed ID: 29033278)
1. Different profiles of upper limb function in four types of neuromuscular disorders.
Bergsma A; Janssen MMHP; Geurts ACH; Cup EHC; de Groot IJM
Neuromuscul Disord; 2017 Dec; 27(12):1115-1122. PubMed ID: 29033278
[TBL] [Abstract][Full Text] [Related]
2. Upper extremity function and activity in facioscapulohumeral dystrophy and limb-girdle muscular dystrophies: a systematic review.
Bergsma A; Cup EH; Geurts AC; de Groot IJ
Disabil Rehabil; 2015; 37(12):1017-32. PubMed ID: 25098592
[TBL] [Abstract][Full Text] [Related]
3. Upper limb function and activity in people with facioscapulohumeral muscular dystrophy: a web-based survey.
Bergsma A; Cup EH; Janssen MM; Geurts AC; de Groot IJ
Disabil Rehabil; 2017 Feb; 39(3):236-243. PubMed ID: 26942834
[TBL] [Abstract][Full Text] [Related]
4. Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy based analysis.
Srivastava NK; Yadav R; Mukherjee S; Sinha N
Clin Chim Acta; 2018 Mar; 478():171-181. PubMed ID: 29278724
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and effectiveness of a novel dynamic arm support in persons with spinal muscular atrophy and duchenne muscular dystrophy.
Janssen MMHP; Horstik J; Klap P; de Groot IJM
J Neuroeng Rehabil; 2021 May; 18(1):84. PubMed ID: 34020668
[TBL] [Abstract][Full Text] [Related]
6. Towards a short questionnaire for stepwise assessment of upper limb function, pain and stiffness in Duchenne muscular dystrophy.
Janssen MMHP; Geurts ACH; de Groot IJM
Disabil Rehabil; 2018 Apr; 40(7):842-847. PubMed ID: 28084836
[TBL] [Abstract][Full Text] [Related]
7. Frequency of reported pain in adult males with muscular dystrophy.
Jacques MF; Stockley RC; Bostock EI; Smith J; DeGoede CG; Morse CI
PLoS One; 2019; 14(2):e0212437. PubMed ID: 30763387
[TBL] [Abstract][Full Text] [Related]
8. Abnormal lipid metabolism in skeletal muscle tissue of patients with muscular dystrophy: In vitro, high-resolution NMR spectroscopy based observation in early phase of the disease.
Srivastava NK; Yadav R; Mukherjee S; Pal L; Sinha N
Magn Reson Imaging; 2017 May; 38():163-173. PubMed ID: 28069416
[TBL] [Abstract][Full Text] [Related]
9. Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies.
García-Giménez JL; García-Trevijano ER; Avilés-Alía AI; Ibañez-Cabellos JS; Bovea-Marco M; Bas T; Pallardó FV; Viña JR; Zaragozá R
Orphanet J Rare Dis; 2022 Dec; 17(1):450. PubMed ID: 36575500
[TBL] [Abstract][Full Text] [Related]
10. Muscular Dystrophies.
Carter JC; Sheehan DW; Prochoroff A; Birnkrant DJ
Clin Chest Med; 2018 Jun; 39(2):377-389. PubMed ID: 29779596
[TBL] [Abstract][Full Text] [Related]
11. Decreased bone mineral density in adult patients with muscular dystrophy.
Philippe V; Pruna L; Abdel Fattah M; Pascal V; Kaminsky P
Joint Bone Spine; 2011 Dec; 78(6):651-2. PubMed ID: 21727019
[No Abstract] [Full Text] [Related]
12. Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy.
Matsuzaka Y; Kishi S; Aoki Y; Komaki H; Oya Y; Takeda S; Hashido K
Environ Health Prev Med; 2014 Nov; 19(6):452-8. PubMed ID: 25150707
[TBL] [Abstract][Full Text] [Related]
13. Muscle MRI findings in facioscapulohumeral muscular dystrophy.
Gerevini S; Scarlato M; Maggi L; Cava M; Caliendo G; Pasanisi B; Falini A; Previtali SC; Morandi L
Eur Radiol; 2016 Mar; 26(3):693-705. PubMed ID: 26115655
[TBL] [Abstract][Full Text] [Related]
14. Measurement of the functional status of patients with different types of muscular dystrophy.
Lue YJ; Lin RF; Chen SS; Lu YM
Kaohsiung J Med Sci; 2009 Jun; 25(6):325-33. PubMed ID: 19560997
[TBL] [Abstract][Full Text] [Related]
15. New developments in exon skipping and splice modulation therapies for neuromuscular diseases.
Touznik A; Lee JJ; Yokota T
Expert Opin Biol Ther; 2014 Jun; 14(6):809-19. PubMed ID: 24620745
[TBL] [Abstract][Full Text] [Related]
16. A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort.
Megarbane A; Bizzari S; Deepthi A; Sabbagh S; Mansour H; Chouery E; Hmaimess G; Jabbour R; Mehawej C; Alame S; Hani A; Hasbini D; Ghanem I; Koussa S; Al-Ali MT; Obeid M; Talea DB; Lefranc G; Lévy N; Leturcq F; El Hayek S; Delague V; Urtizberea JA
J Neuromuscul Dis; 2022; 9(1):193-210. PubMed ID: 34602496
[TBL] [Abstract][Full Text] [Related]
17. Oral health considerations in muscular dystrophies.
Balasubramaniam R; Sollecito TP; Stoopler ET
Spec Care Dentist; 2008; 28(6):243-53. PubMed ID: 19068065
[TBL] [Abstract][Full Text] [Related]
18. Variables associated with upper extremity function in patients with Duchenne muscular dystrophy.
Janssen MM; Hendriks JC; Geurts AC; de Groot IJ
J Neurol; 2016 Sep; 263(9):1810-8. PubMed ID: 27314968
[TBL] [Abstract][Full Text] [Related]
19. Patterns of decline in upper limb function of boys and men with DMD: an international survey.
Janssen MM; Bergsma A; Geurts AC; de Groot IJ
J Neurol; 2014 Jul; 261(7):1269-88. PubMed ID: 24687893
[TBL] [Abstract][Full Text] [Related]
20. Manual ability and upper limb performance in nonambulatory stage of Duchenne muscular dystrophy.
Demir G; Bulut N; Yılmaz Ö; Karaduman A; Alemdaroğlu-Gürbüz İ
Arch Pediatr; 2020 Aug; 27(6):304-309. PubMed ID: 32718814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
